Insulet Corp (PODD): Market Cap to Revenue

Symbol and logo of brand Insulet Corp (PODD)

Insulet Corporation (PODD) is implementing eco-friendly plastic recycling and clean energy, which supports the company's historical P/S ratio, currently priced at 3.30. Effective management is scaling sales of tubeless pumps while maintaining transparency in testing. Simultaneously, Insulet Corporation (PODD) is optimizing expenses by outsourcing housing production to external partners while retaining internal control over sterile assembly and software.

PODD Insulet Corp P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for OmniPod (PODD)

- share price and consensus valuation forecast:
Price Performance Chart insulet.com|PODD - Price Target Chart
- stock exchange capitalization data:
Market Valuation OmniPod|PODD - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Insulet|PODD - Book Capitalization|Capitalization to Book Value Ratio insulet.com|PODD - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Insulet Corporation|PODD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Insulet Inc.|PODD - Company Aggregate Debts|Debts to Book Capitalization OmniPod|PODD - Company Long-Term Debt|Company Short-Term Debt Insulet|Intermediate Coverage Ratio insulet.com
- earnings and multiples data:
PODD - Net Profit|Expected Net Profit Insulet Corporation|PODD - Price to Earnings Ratio|Forward Price to Earnings Multiple Insulet Corp|PODD - Price/Earnings to Growth Multiple|EV/EBITDA Multiple OmniPod|PODD - Operating profit EBITDA|Net earnings per share for the last four quarters Insulet|PODD - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months insulet.com|PODD - Earnings per share growth in current year|Expected earnings per share growth for next year Insulet Corporation
- issuer revenue and sales details:
PODD - Revenue and Sales Volume|Company Expected Sales Volume insulet.com|PODD - Price-to-Revenue Ratio|Market Cap to Projected Revenue OmniPod
General company analysis:PODD insulet.com
Core merchandise of Insulet Corporation

The efficiency of Insulet Corporation (PODD) in the insulin pump segment requires constant monitoring amid the expansion of GLP-1 drugs. By analyzing price-to-sales dynamics, an investor compares market capitalization with annual revenue, which allows for the determination of the cost of each dollar of sales and an assessment of the asset's premium, confirming the business's resilience to market volatility and competitive pressure.

Competitors of Insulet Corporation

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|Zimmer - P/S Multiple|Price to Sales CooperSurgical|ALGN: P/S Multiple|Market Cap to Revenue Ratio GMED|TMDX (TransMedics Group, Inc.) - P/S Multiple|Alphatec Holdings (ATEC) - Price-to-Revenue Coefficient|P/S Multiple AORT|Market Cap to Revenue Enovis Inc. ENOV|P/S Multiple IART (Integra LifeSciences)|P/S Multiple establishmentlabs.com ESTA|BBNX - Price-to-Revenue Ratio|IRMD: Price-to-Revenue Ratio|EMBC (Embecta Inc.) - Market Cap to Revenue|Tandem Corp - Market Capitalization-to-Revenue Ratio|AXGN (AxoGen, Inc.) - P/S Multiple|Price to Sales si-bone.com SIBN|Price-to-Revenue Ratio Orthofix (OFIX)|Bioventus Inc (BVS) - Price-to-Revenue Multiple|OrthoPediatrics - Market Cap to Revenue|P/S Multiple Treace Corp TMCI|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|XTNT: P/S Multiple|NMTC - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Modular Medical Inc|Market Cap to Revenue Ratio MYO (Myomo Inc.)|Price-to-Revenue Ratio Envoy Medical, Inc (COCH)|Price-to-Revenue Coefficient Vivos Therapeutics Inc|enVVeno Medical - Market Cap to Revenue|P/S Multiple Sintx Technologies Inc SINT|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|AMIX: P/S Multiple|Price to Sales INVO Fertility Corp (IVF)|Market Cap to Revenue BBLG|AXNX (axonics.com) - Market Cap to Sales Volume|Market Cap to Revenue BIOL (BIOLASE)|DYNT (dynatronics.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple FNA (Paragon 28)|INVO - Market Cap to Revenue